Fairmount Funds Management LLC
Fairmount Funds Management LLC is a Philadelphia-based hedge fund established in 2020. The firm specializes in managing life sciences and healthcare-focused investment vehicles, catering primarily to institutional investors. As of March 2025, Fairmount manages approximately $3.2 billion in assets and employs over 30 professionals, nearly half of whom are investment staff. The firm is known for its concentrated, research-driven approach to growth and event-driven strategies within biotechnology and healthcare.
Investment Strategy
Fairmount Funds Management LLC employs a fundamental, research-driven investment approach, with a primary focus on life sciences and healthcare companies, especially those in the biotechnology sector. The firm seeks both public and private investment opportunities with a bias toward long-term value creation and company-specific catalysts. Fairmount favors a concentrated portfolio, aiming for deep understanding and engagement with a select group of high-conviction positions, often participating in company financings and taking active ownership roles where appropriate.
Top Holdings
Equity Positions (17)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A APGE | APOGEE THERAPEUTICS INC | 11.53% | $89.0M | 2,048,647 | $21.30 | $43.43 | +$12.4M |
A AXSM | AXSOME THERAPEUTICS INC | 11.02% | $85.1M | 815,176 | $50.70 | $104.39 | -$10.0M |
E ELVN | ENLIVEN THERAPEUTICS INC | 9.65% | $74.5M | 3,711,444 | $20.69 | $20.06 | +$11.4M |
S SRRK | SCHOLAR ROCK HLDG CORP | 8.37% | $64.6M | 1,824,031 | $41.30 | $35.42 | +$20.4M |
S SYRE | SPYRE THERAPEUTICS INC | 7.79% | $60.2M | 4,018,101 | $23.39 | $14.97 | -$4.7M |